Reeve Emma sold PTCT
September 11, 2025 · Form 4 insider transaction
Reeve Emma sold 837 shares of PTC Therapeutics, Inc. at $59.50 per share, a transaction worth $49.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
837
Price
$59.50
Total value
$49.8K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2025
Filing dateSeptember 16, 2025
Shares owned after10,332
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.